Hyunkyung Kong, Ph.D., joined the Laboratory of Translational Genomics (LTG) in 2017 as a postdoctoral fellow in the laboratory of Kevin Brown, Ph.D., senior investigator. Dr. Kong completed her M.S. − Ph.D. unified course in biological sciences from Sookmyung Women’s University, South Korea. There, working with Dr. Jong Hoon Park, she focused on the genetic analysis and epigenetic mechanisms regulating drug susceptibility of breast cancer using a diverse panel of breast cancer cell lines and patient samples.
Dr. Kong's work focuses on the functional characterization of susceptibility variants identified by genome-wide association studies, and how they influence the risk of melanoma, under the mentorship of Dr. Brown.